CD133 was used in the initial studies on colon CSCs, revealing that CD133+ cells isolated from colorectal cancer exhibited the properties of self-renewal and high tumorigenic potential, compared with CD133- cells, which were unable to initiate tumor growth (26,27). The gene discussed is PROM1; the disease is colorectal cancer.